ASTH — APOLLO MED HLDGS INC

Ownership history in QUADRANT CAPITAL GROUP LLC  ·  12 quarters on record

This page tracks every 13F SEC filing in which QUADRANT CAPITAL GROUP LLC reported a position in APOLLO MED HLDGS INC (ASTH). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2023 Q1)
Avg. % of fund
0.0%
First filed
2022 Q3
Last filed
2025 Q3
Quarters held
12
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 18 -3,365 -99.5% 0.00% $511 $28.35
2025 Q1 ADDED 3,383 +2,601 +332.6% 0.00% $105K $31.01
2024 Q4 REDUCED 782 -180 -18.7% 0.00% $25K $31.53
2024 Q3 UNCHANGED 962 — 0% 0.00% $56K $57.94
8 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    ASTH price (monthly, adj. close)

Other funds also holding ASTH

As of 2025 Q4 — sorted by position size

325 CAPITAL LLC 3Y 15.99% 1492 Capital Management LLC 3Y 7Y 1.59% QSV Equity Investors LLC 1.09% SteelPeak Wealth, LLC 3Y 0.47% Insight Wealth Strategies, LLC 3Y 7Y 0.4% HUSSMAN STRATEGIC ADVISORS, INC. 3Y 7Y 0.38% Shay Capital LLC 3Y 0.31% Capstone Capital Management Ltd 0.28% NorthCrest Asset Manangement, LLC 3Y 0.28% ROYCE & ASSOCIATES LP 3Y 7Y 0.09%
← Back to QUADRANT CAPITAL GROUP LLC Holdings